Liquid biopsies in the era of immuno-oncology
This review, published in the Annals of Oncology, discusses the [...]
ESMO 2019: Neurologic complications of immunotherapy
This interview with Dr Matthias Preusser from the Medical University of [...]
ESMO 2019: ADAPTeR study to evaluate the role of nivolumab before and after surgery – results of biomarker analysis
Results from the ADAPTeR study to evaluate the role of [...]
Effect of antibiotic use on outcomes with systemic therapies in metastatic kidney cancer
This study, published in European Urology Oncology this week, investigated [...]
ESMO 2019: Results from the TRAXAR study to assess TRC105 plus axitinib for metastatic kidney cancer
Results from the TRAXAR clinical trial to assess TRC105 plus [...]
ESMO 2019: Results from JAVELIN-Renal 101 trial for sarcomatoid kidney cancer
Results from the JAVELIN-Renal 101 clinical trial to assess avelumab [...]
ESMO 2019: Results from TITAN-RCC tailored immunotherapy clinical trial
Results from the TITAN-RCC clinical trial to assess tailored immunotherapy [...]
Immune checkpoint inhibitors are more effective in PD-L1 positive patients
Immune checkpoint inhibitors, such as nivolumab, ipilimumab or pembrolizumab are [...]
Personalised immunotherapy for advanced kidney cancer
In this video interview, Dr David Braun from the Dana-Farber [...]
Cytoreductive surgery with immunotherapy for kidney cancer patients
In this video clip, Professor Eric Jonasch, Medical Oncologist, Division [...]
